Navigation Links
Talecris Biotherapeutics Announces Revised Record Date and Meeting Date for Special Meeting of Shareholders
Date:1/14/2011

RESEARCH TRIANGLE PARK, N.C., Jan. 14, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) announced today that it has established a new record date and meeting date for the special meeting of shareholders to vote on the previously announced merger agreement under which Grifols (GRF.MC) will acquire TLCR.

TLCR shareholders of record at the close of business on January 11, 2011 will be entitled to vote at the special meeting.  The TLCR board set the date for the special meeting of shareholders to be held at 3:30 p.m., local time, on February 14, 2011, at Research Triangle Park Marriott, located at 4700 Guardian Drive, Durham, North Carolina 27703.  This date takes the place of the previously announced date of January 21, 2011.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.


'/>"/>
SOURCE Talecris Biotherapeutics Holdings Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Talecris Biotherapeutics Announces Jury Verdict in Contract Dispute
2. Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting
3. Talecris Biotherapeutics to Report Second Quarter 2010 Financial Results
4. Talecris Biotherapeutics Announces Premerger HSR Filing
5. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
6. Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
7. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
8. Talecris Added to NASDAQ Biotechnology Index
9. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
10. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
11. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... San Diego, CA (PRWEB) , ... ... ... BioInformatics (https://www.onramp.bio/ ) has launched Rosalindâ„¢, the first-ever genomics analysis platform ... eliminating all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
Breaking Biology News(10 mins):